SEVERE APLASTIC ANEMIA (SAA)
Clinical trials for SEVERE APLASTIC ANEMIA (SAA) explained in plain language.
Never miss a new study
Get alerted when new SEVERE APLASTIC ANEMIA (SAA) trials appear
Sign up with your email to follow new studies for SEVERE APLASTIC ANEMIA (SAA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to free aplastic anemia patients from transfusions
Disease control Not yet recruitingThis study tests a combination of three drugs (cyclosporine, eltrombopag or hetrombopag, and romiplostim) in adults newly diagnosed with severe aplastic anemia or transfusion-dependent non-severe aplastic anemia. The goal is to see if this treatment can improve blood cell counts …
Matched conditions: SEVERE APLASTIC ANEMIA (SAA)
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated May 17, 2026 03:09 UTC
-
New hope for rare blood disorder: drug cocktail aims to restore blood cell production
Disease control Not yet recruitingThis study tests a combination of three drugs (cyclosporine, eltrombopag or hetrombopag, and romiplostim) in 43 adults newly diagnosed with severe aplastic anemia, a condition where the bone marrow fails to produce enough blood cells. The goal is to see if this treatment can help…
Matched conditions: SEVERE APLASTIC ANEMIA (SAA)
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated May 17, 2026 02:59 UTC